Chuan Zhang Selected Research

Chuan Zhang Research Topics

Disease

67	Neoplasms (Cancer) 10/2022 - 07/2015
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
13	Neoplasm Metastasis (Metastasis) 11/2021 - 07/2007
11	Stroke (Strokes) 01/2022 - 06/2006
10	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2016
10	Inflammation (Inflammations) 01/2022 - 11/2003
8	Carcinogenesis 04/2022 - 01/2016
7	Hypoxia (Hypoxemia) 01/2021 - 11/2017
6	Infections 01/2022 - 02/2005
5	Gastroesophageal Reflux (GERD) 02/2022 - 12/2018
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2006
5	Colitis 12/2021 - 12/2011
4	Non-alcoholic Fatty Liver Disease 10/2022 - 11/2012
4	Heart Failure 09/2022 - 02/2015
4	Phenylketonurias (Phenylketonuria) 01/2022 - 12/2014
4	Wounds and Injuries (Trauma) 01/2022 - 10/2014
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
4	Myocardial Infarction 12/2019 - 01/2006
3	Cardiac Arrhythmias (Arrythmia) 09/2022 - 04/2015
3	Ischemic Stroke 08/2022 - 10/2017
3	Rheumatoid Arthritis 01/2022 - 05/2021
3	Hyperplasia 05/2021 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 05/2021 - 08/2018
3	Hyperthermia 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 01/2017
3	Congenital Abnormalities (Deformity) 01/2020 - 08/2017
3	Hyperglycemia 01/2016 - 01/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 03/2017
2	Hypertrophic Cicatrix (Hypertrophic Scar) 02/2022 - 09/2020
2	Hemiplegia (Spastic Hemiplegia) 01/2022 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 04/2019
2	Ulcerative Colitis 12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

27	Pharmaceutical PreparationsIBA 02/2022 - 01/2013
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2017
10	Nucleic AcidsIBA 02/2022 - 05/2018
8	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2019
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2002
6	Therapeutic UsesIBA 05/2022 - 08/2017
6	Biological ProductsIBA 05/2022 - 07/2006
6	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2019
6	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2018
6	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 01/2017
5	Circular RNAIBA 04/2022 - 01/2021
5	Long Noncoding RNAIBA 01/2022 - 01/2019
5	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 01/2020
5	Peptides (Polypeptides)IBA 10/2021 - 11/2017
5	erucylphosphocholineIBA 01/2021 - 01/2016
5	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2018
5	Oxygen (Dioxygen)IBA 10/2020 - 05/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 11/2003
4	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2022 - 12/2014
4	AcidsIBA 01/2022 - 01/2018
4	CytokinesIBA 11/2021 - 01/2021
4	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
4	3,4-dihydroxyphenyllactic acidIBA 05/2020 - 01/2018
4	Insulin (Novolin)FDA Link 01/2017 - 01/2012
3	EnzymesIBA 01/2022 - 06/2007
3	NucleosidesIBA 01/2022 - 07/2015
3	Pepsin A (Pepsin)IBA 08/2021 - 12/2018
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2012
3	A-Form DNA (A-DNA)IBA 01/2021 - 08/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2007
3	Triglycerides (Triacylglycerol)IBA 12/2020 - 11/2012
3	Dextran SulfateIBA 11/2020 - 12/2011
3	ProdrugsIBA 01/2020 - 11/2017
3	Hematoxylin (Haematoxylon)IBA 01/2020 - 02/2005
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 02/2005
3	NanogelsIBA 06/2019 - 05/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 10/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 11/2017
3	OzoneIBA 01/2018 - 04/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 06/2005
3	astragaloside AIBA 07/2006 - 01/2006
2	Fluorescent Dyes (Fluorescent Probes)IBA 10/2022 - 04/2019
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2022 - 04/2017
2	Hyaluronic Acid (Hyaluronan)IBA 02/2022 - 07/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 09/2020
2	glaucocalyxin AIBA 01/2022 - 05/2021
2	PeriostinIBA 01/2022 - 11/2020
2	gamabufotalinIBA 01/2022 - 11/2020
2	TensinsIBA 01/2022 - 01/2019
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 11/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2017
2	Untranslated RNA (Noncoding RNA)IBA 11/2021 - 11/2020
2	PolymersIBA 10/2021 - 01/2021
2	RadiopharmaceuticalsIBA 10/2021 - 01/2021
2	Radioisotopes (Radionuclides)IBA 10/2021 - 01/2021

Therapy/Procedure

32	Therapeutics 09/2022 - 12/2011
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
6	Injections 01/2022 - 01/2017
5	Length of Stay 01/2019 - 09/2011
4	Immunotherapy 07/2021 - 08/2018
3	Ligation 01/2019 - 01/2006
3	Osteotomy 10/2018 - 08/2017
3	Catheters 01/2018 - 04/2017
3	Denervation 01/2018 - 11/2003
3	Photochemotherapy (Photodynamic Therapy) 01/2018 - 11/2017
2	Intravenous Injections 05/2022 - 04/2019
2	Radiotherapy 01/2022 - 10/2021